Which FLT3 Inhibitor for Treatment of AML?

Published in: Current treatment options in oncology (2022)

AML (esp. ITD) to proceed to allo-SCT with regimens containing FLT3i incorporated prior to SCT and as maintenance after SCT.

Keyphrases